SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-376707
Filing Date
2015-11-13
Accepted
2015-11-13 11:44:00
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d92891d10q.htm 10-Q 452760
2 EX-31.1 d92891dex311.htm EX-31.1 7860
3 EX-31.2 d92891dex312.htm EX-31.2 7753
4 EX-32.1 d92891dex321.htm EX-32.1 3568
5 EX-32.2 d92891dex322.htm EX-32.2 3523
  Complete submission text file 0001193125-15-376707.txt   3337853

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vtvt-20150930.xml EX-101.INS 433306
7 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20150930.xsd EX-101.SCH 50481
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20150930_cal.xml EX-101.CAL 54372
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20150930_def.xml EX-101.DEF 203554
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20150930_lab.xml EX-101.LAB 404825
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20150930_pre.xml EX-101.PRE 282671
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 151227782
SIC: 2834 Pharmaceutical Preparations